home / stock / beam / beam articles

BEAM Articles, Beam Therapeutics Inc.

Stock Information
Company Name: Beam Therapeutics Inc.
Stock Symbol: BEAM
Market: NASDAQ
Website: beamtx.com
Menu
BEAM BEAM Quote BEAM Short BEAM News BEAM Articles BEAM Message Board
Get BEAM Alerts

News, Short Squeeze, Breakout and More Instantly...
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast | Benzinga

On Thursday, Cathie Wood’s Ark Invest made a significant move by reducing its stake in Tesla Inc (NASDAQ:TSLA), despite a recent bullish outl...
Beam Therapeutics Announces Transition of Chief Financial Officer | Benzinga

CAMBRIDGE, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic m...

Here's Why You Should Invest in Beam Therapeutics Now | Benzinga

Beam Therapeutics Inc. (NASDAQ: BEAM) is evaluating its leading ex-vivo genome-editing candidate, BEAM-101, in the phase I/II BEACON study for the ...

Beam Therapeutics Begins Dosing in Phase I/II AATD Study | Benzinga

Beam Therapeutics Inc. (NASDAQ: BEAM) announced that it has dosed the first patient in the phase I/II study, evaluating its investigational in vivo...
Beam Therapeutics to Participate in Jefferies Global Healthcare Conference | Benzinga

CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic me...

Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid Congress | Benzinga

CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic me...

Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference | Benzinga

CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic me...
Popular Crypto Trader Shares 2024 Predictions For These Three Altcoins | Benzinga

Popular pseudonymous crypto analyst Altcoin Sherpa on Friday shared his insights on three altcoins: Beam (CRYPTO: BEAM), Arbitrum (CRYPTO: ARB), an...

Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol | Benzinga

Verve Therapeutics Inc (NASDAQ:VERV) announced an update from the Heart-1 Phase 1b trial of VERVE-101. VERVE-101 is being evaluated in pa...

Beam Therapeutics to Participate in Upcoming March 2024 Investor Conferences | Benzinga

CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company developing precision genetic m...
Next 10